Treatment of a first patient with FLASH-radiotherapy-Reference-Cited by-同舟云学术

Treatment of a first patient with FLASH-radiotherapy

Published:2019-10 Issue: Volume:139 Page:18-22
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Bourhis Jean^ORCID,Sozzi Wendy Jeanneret,Jorge Patrik Gonçalves,Gaide Olivier,Bailat Claude,Duclos Fréderic,Patin David,Ozsahin Mahmut,Bochud François^ORCID,Germond Jean-François,Moeckli Raphaël^ORCID,Vozenin Marie-Catherine^ORCID

Funder

Fond’action

FNS

ISREC Foundation

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference20 articles.

1. Hyperfractionated or accelerated RT in head and neck cancer: a meta-analysis;Bourhis;Lancet,2006

2. Parotid-sparing intensity modulated versus conventional RT in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial;Nutting;Lancet Oncol,2011

3. European Organisation for Research and Treatment of Cancer recommendations for planning and delivery of high-dose, high-precision RT for lung cancer;De Ruysscher;J Clin Oncol,2010

4. Ultrahigh dose-rate FLASH irradiation increases the differential response between normal and tumor tissue in mice;Favaudon;Sci Transl Med,20146

5. Ultrahigh dose-rate RT: next steps for FLASH-RT;Harrington;Clin Cancer Res,2018

Cited by 460 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research on Survival of A549 Tumor Cells Following Proton Beam Irradiation Using FLASH Radiotherapy and Conventional Dose Rate Irradiation;Биофизика;2024-12-15

2. Alanine/electron spin resonance dosimetry for FLASH radiotherapy;Radiation Physics and Chemistry;2024-12

3. Radiotherapeutic advances in the management of glioblastoma;Journal of Neuro-Oncology;2024-09-13

4. FLASH Radiotherapy Versus Conventional Cancer Therapy: Promises, Paradoxes and Problems;International Journal of Translational Medicine;2024-09-11

5. Recording and reporting of ultra-high dose rate “FLASH” delivery for preclinical and clinical settings;Radiotherapy and Oncology;2024-09